Questions: Passive vs. Active Disease Surveillance

Question 1

During the early weeks of a novel respiratory illness, a health department relies entirely on its passive surveillance system and reports low case counts. An epidemiologist argues this dramatically underestimates true burden. What is the most likely explanation?

• A. The disease is not on the notifiable disease list, so providers have no legal obligation to report it
• B. Passive systems consistently capture only a fraction of true cases — clinicians may not recognize a novel presentation, may lack time to report, or cases may never reach a healthcare provider at all
• C. Active surveillance would find even fewer cases because it focuses only on pre-selected high-risk populations
• D. Passive surveillance overcounts cases because providers report suspected rather than confirmed diagnoses

Answer: (B)

Passive surveillance captures an estimated 10–50% of true cases even for well-established notifiable diseases. For a novel illness with non-specific presentation, ascertainment is even lower: clinicians may not recognize it, may attribute symptoms to other causes, or may not have time to file reports. This systematic under-ascertainment is the defining limitation of passive systems and explains why passive case counts should never be treated as complete.

Question 2

Why don't countries use active surveillance for all notifiable diseases simultaneously?

• A. Active surveillance produces lower-quality data than passive surveillance because it involves proactive contact rather than spontaneous reporting
• B. Legal frameworks for notifiable disease reporting prohibit active surveillance methods
• C. Active surveillance requires dedicated staff making proactive contacts with providers and labs, which is not sustainable at scale across hundreds of diseases
• D. Passive surveillance already achieves complete case ascertainment, making active surveillance redundant

Answer: (C)

Active surveillance dramatically improves case ascertainment and outbreak detection speed, but it requires dedicated personnel making ongoing outgoing contacts — phone calls, data requests, lab cross-references. This is resource-intensive and simply cannot be maintained for all diseases simultaneously. The practical solution is to use passive surveillance broadly and deploy active surveillance selectively: for outbreak investigations, elimination-targeted diseases, novel pathogens, and sentinel sites that provide early warning.

Question 3

Passive surveillance systems reliably capture the majority of disease cases because healthcare providers are legally required to report notifiable diseases.

• T. True
• F. False

Answer: False

Legal reporting requirements do not translate into complete case ascertainment. Studies comparing passive surveillance counts to active case-finding consistently find passive systems capture only 10–50% of true cases. Providers forget to report, lack time, may not make the correct diagnosis, and many cases (especially mild or asymptomatic ones) never reach a healthcare provider at all. The legal obligation creates infrastructure but does not overcome the fundamental behavioral and diagnostic barriers to complete reporting.

Question 4

Sentinel surveillance networks — small sets of designated sites that actively report specific syndromes — represent a middle path that provides better data quality than pure passive reporting without requiring universal active surveillance.

• T. True
• F. False

Answer: True

Sentinel surveillance is a hybrid architecture. Instead of relying on spontaneous reporting from all providers (passive) or proactively contacting every provider about every disease (universal active), sentinel systems designate a few hundred hospitals or clinics that commit to thorough, active reporting of specific conditions. This provides early warning signals and richer data quality at a fraction of the cost of universal active surveillance.

Question 5

Why does the choice of surveillance system matter when interpreting disease case count data?

Model answer: The surveillance system determines how many true cases are captured. Passive systems miss 50–90% of cases, so counts reflect reporting behavior as much as disease burden. Active systems approach more complete ascertainment. An apparent 'increase' in cases may reflect a switch from passive to active surveillance rather than a genuine outbreak. Knowing which system generated a dataset is essential for deciding whether it can support claims about true incidence, outbreak detection, or trend analysis.

This is a general principle of data interpretation: the measurement instrument shapes what you observe. A passive surveillance dataset is not a census of disease — it is a record of reported cases, filtered through clinician behavior, diagnostic capacity, and reporting compliance. If you compare case counts across time periods that used different surveillance approaches, or across countries with different surveillance architectures, you are comparing apples and oranges unless you account for the ascertainment fraction.